66 results on '"Lassila R"'
Search Results
2. OC 62.2 Antiplatelet and Anticoagulant Compound (APAC) Restricts Thromboinflammation to Ameliorates Myocardial Ischemia Reperfusion Injury
3. PB1245 Efficacy, Safety and Dosing of Pasteurized Plasma-Derived von Willebrand Factor/Factor VIII Concentrate for the Treatment of von Willebrand Disease: A Systematic Review
4. APAC treatment limits collar-induced carotid atherosclerotic plaque development in apoE-/- mice
5. APAC treatment limits collar-induced carotid atherosclerotic plaque development in apoE-/- mice
6. Neoadjuvant Treatment and the Prolonged Risk of Venous Thromboembolism in Resectable Pancreatic Cancer
7. 3. Heparin-induced thrombocytopenia
8. Levels of the cancer biomarker CA 19-9 are associated with thrombin generation in plasma from treatment-naïve pancreatic cancer patients
9. Neoadjuvant Therapy and Venous Thromboembolism after Surgery in Pancreatic Cancer
10. PF797 APAC, A DUAL ANTIPLATELET AND ANTICOAGULANT - TOWARDS A LOCAL, VASCULAR TARGETING ANTITHROMBOTIC
11. Abnormal coagulation and enhanced fibrinolysis due to lysinuric protein intolerance associates with bleeds and renal impairment
12. P6559APAC, a dual antiplatelet and anticoagulant, attenuates platelet procoagulant activity and localizes to extravascular matrix during vascular injury
13. Long-term clinical and economic outcomes in previously untreated paediatric patients with severe haemophilia A: A nationwide real-world study with 700 person-years
14. Comprehensive re-evaluation of historical von Willebrand disease diagnosis in association with whole blood platelet aggregation and function
15. Characterization Of Health Care Utilization And Cost Of Hemophilia A And B In Real-Life: A 4-Year Follow-UP Study In Finland
16. Weekly recombinant FIX prophylaxis for severe haemophilia B in normal clinical practice: data from UKHCDO and Finland
17. Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity
18. Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series
19. Can Vascular Calcification be Associated with Warfarin Treatment?
20. Inhibitor development in previously untreated patients with severe haemophilia A: a nationwide multicentre study in Finland
21. Safety surveillance in haemophilia and allied disorders
22. Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland
23. Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy
24. Thrombosis on Stenosis: Mechanisms of Thrombus Growth and Embolization on Carotid Atherosclerotic Plaques
25. Managing Haemophilia for Life: 4th Haemophilia Global Summit
26. Erik von Willebrand
27. Phenotypic and genotypic characterization of 10 Finnish patients with von Willebrand disease type 3: discovery of two main mutations
28. Prevalence of Thrombophilia and Thrombogenic Factors among 122 Heart Transplant Recipients
29. P-025 Adrenomedullin is associated with von Willebrand factor activity in non-pregnant but not in pregnant women
30. von Willebrand's disease: a report from a meeting in the Åland islands
31. Role and Management of Coagulation Disorders in Peripheral Arterial Disease
32. 787 Oral dabigatran etexilate for the prevention of venous thromboembolism after robotic prostatectomy
33. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial
34. Management of Postpartum Hemorrhage
35. Platelets significantly modify procoagulant activities in haemophilia A
36. EUHASS: The European Haemophilia Safety Surveillance system
37. Management of post-partum haemorrhage
38. Current challenges of pharmacovigilance in bleeding disorders: converting the burden to benefit
39. Pseudoaneurysm in association with a knee endoprothesis operation in an inhibitor-positive haemophilia A patient - treatment with local thrombin
40. FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations
41. Early thrombin generation and impaired fibrinolysis after SCT associate with acute GVHD
42. Migration at early age from a high to a lower coronary heart disease risk country lowers the risk of subclinical atherosclerosis in middle-aged men
43. Successful Liver-Kidney Transplantation in Two Children With aHUS Caused by a Mutation in Complement Factor H
44. Protease‐activated receptor‐induced Akt activation – regulation and possible function
45. Management of acute myocardial infarction in a patient with factor XIII deficiency using prophylactic factor replacement therapy
46. Interplay between Coagulation and Inflammation in Open and Endovascular Abdominal Aortic Aneurysm Repair — Impact of Intra-Aneurysmal Thrombus
47. PO19-567 SERUM ADIPONECTIN LEVELS ASSOCIATE WITH TISSUE-TYPE PLASMINOGEN ACTIVATOR ACTIVITY IN PATIENTS WITH ADVANCED CAROTID ATHEROSCLEROSIS
48. Thrombin generation during reperfusion after coronary artery bypass surgery associates with postoperative myocardial damage
49. Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjects
50. Tyrosine kinases regulate the activation of phosphatidylinositol 3-kinase in platelets stimulated by the PAR1-activating peptide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.